ARRY:NSD-Array BioPharma Inc. (USD)

EQUITY | Solar | NASDAQ Global Market

Last Closing

USD 12.24

Change

-0.38 (-3.01)%

Market Cap

USD 1.31B

Volume

8.04M

Analyst Target

USD 44.29
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Array BioPharma Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Solar

Symbol Name Price(Change) Market Cap
FSLR First Solar Inc

-2.17 (-1.09%)

USD 20.99B
ENPH Enphase Energy Inc

-0.60 (-0.72%)

USD 12.49B
RUN Sunrun Inc

-0.05 (-0.35%)

USD 3.14B
SEDG SolarEdge Technologies Inc

+0.12 (+0.72%)

USD 1.01B
SHLS Shoals Technologies Group Inc

+0.03 (+0.57%)

USD 0.81B
CSIQ Canadian Solar Inc

+0.12 (+0.86%)

USD 0.81B
CSLR Complete Solaria, Inc. Common ..

+0.04 (+1.86%)

USD 0.15B
MAXN Maxeon Solar Technologies Ltd

+2.41 (+38.68%)

USD 0.09B
FTCI FTC Solar Inc

-0.05 (-9.25%)

USD 0.08B
TYGO Tigo Energy Inc.

-0.06 (-5.04%)

USD 0.08B

ETFs Containing ARRY

ZERO:PA 3.92 % 0.00 %

N/A

N/A
SOLR:SW Invesco Solar Energy UCIT.. 3.20 % 0.00 %

+0.21 (+-0.09%)

N/A
PBD Invesco Global Clean Ener.. 0.00 % 0.75 %

-0.10 (-0.09%)

N/A
TAN Invesco Solar ETF 0.00 % 0.65 %

+0.43 (+-0.09%)

N/A
CLMT:CA 0.00 % 0.00 %

N/A

N/A
RAYS Global X Solar ETF 0.00 % 0.00 %

+0.14 (+-0.09%)

USD 6.76M
GCED:LSE Invesco Markets II plc - .. 0.00 % 0.00 %

-0.09 (-0.09%)

USD 1.33M
RAYG:LSE Global X Solar UCITS ETF .. 0.00 % 0.00 %

+0.02 (+-0.09%)

USD 3.39M
ZER0:XETRA 0.00 % 0.00 %

N/A

N/A
RA7Z:XETRA Global X Solar UCITS ETF .. 0.00 % 0.00 %

-0.01 (-0.09%)

USD 3.23M
RAYZ:LSE Global X Solar UCITS ETF .. 0.00 % 0.00 %

+0.02 (+-0.09%)

N/A
TANN:AU BetaShares Solar ETF 0.00 % 0.00 %

-0.12 (-0.09%)

N/A
RAYZ:SW Global X Solar UCITS ETF .. 0.00 % 0.00 %

-0.01 (-0.09%)

USD 3.41M

Market Performance

  Market Performance vs. Industry/Classification (Solar) Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -27.14% 57% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -27.14% 57% F 20% F
Trailing 12 Months  
Capital Gain -46.03% 76% C+ 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -46.03% 76% C+ 20% F
Trailing 5 Years  
Capital Gain -44.01% 40% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -44.01% 40% F 27% F
Average Annual (5 Year Horizon)  
Capital Gain -5.72% 39% F 32% F
Dividend Return -5.72% 39% F 30% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 57.61% 61% D- 28% F
Risk Adjusted Return -9.93% 39% F 35% F
Market Capitalization 1.31B 78% C+ 80% B-

Key Financial Ratios

  Ratio vs. Industry/Classification (Solar) Ratio vs. Market (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 33.21 33% 28%
Price/Book Ratio 7.57 25% 15%
Price / Cash Flow Ratio 8.28 35% 30%
Price/Free Cash Flow Ratio 10.12 36% 26%
Management Effectiveness  
Return on Equity 19.68% 91% 89%
Return on Invested Capital 14.31% 88% 84%
Return on Assets 6.43% 83% 89%
Debt to Equity Ratio 108.26% 24% 21%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.